217 related articles for article (PubMed ID: 27591148)
21. Anti-C1q autoantibodies from active lupus nephritis patients could inhibit the clearance of apoptotic cells and complement classical pathway activation mediated by C1q in vitro.
Pang Y; Yang XW; Song Y; Yu F; Zhao MH
Immunobiology; 2014 Dec; 219(12):980-9. PubMed ID: 25092568
[TBL] [Abstract][Full Text] [Related]
22. Intracapillary immune complexes recruit and activate slan-expressing CD16+ monocytes in human lupus nephritis.
Olaru F; Döbel T; Lonsdorf AS; Oehrl S; Maas M; Enk AH; Schmitz M; Gröne EF; Gröne HJ; Schäkel K
JCI Insight; 2018 Jun; 3(11):. PubMed ID: 29875315
[TBL] [Abstract][Full Text] [Related]
23. The effect of cell death in the initiation of lupus nephritis.
Fenton K
Clin Exp Immunol; 2015 Jan; 179(1):11-6. PubMed ID: 25041590
[TBL] [Abstract][Full Text] [Related]
24. Propylthiouracil-induced diffuse proliferative lupus nephritis: review of immunological complications.
Prasad GV; Bastacky S; Johnson JP
J Am Soc Nephrol; 1997 Jul; 8(7):1205-10. PubMed ID: 9219172
[TBL] [Abstract][Full Text] [Related]
25. Genetic control of glycoprotein 70 autoantigen production and its influence on immune complex levels and nephritis in murine lupus.
Tucker RM; Vyse TJ; Rozzo S; Roark CL; Izui S; Kotzin BL
J Immunol; 2000 Aug; 165(3):1665-72. PubMed ID: 10903778
[TBL] [Abstract][Full Text] [Related]
26. Inhibition of the alternative complement pathway by antisense oligonucleotides targeting complement factor B improves lupus nephritis in mice.
Grossman TR; Hettrick LA; Johnson RB; Hung G; Peralta R; Watt A; Henry SP; Adamson P; Monia BP; McCaleb ML
Immunobiology; 2016 Jun; 221(6):701-8. PubMed ID: 26307001
[TBL] [Abstract][Full Text] [Related]
27. The Role of Autophagy in Lupus Nephritis.
Wang L; Law HK
Int J Mol Sci; 2015 Oct; 16(10):25154-67. PubMed ID: 26506346
[TBL] [Abstract][Full Text] [Related]
28. The Pathogenesis and Therapeutic Implications of Tubulointerstitial Inflammation in Human Lupus Nephritis.
Clark MR; Trotter K; Chang A
Semin Nephrol; 2015 Sep; 35(5):455-64. PubMed ID: 26573548
[TBL] [Abstract][Full Text] [Related]
29. "Pauci-Immune" proliferative and necrotizing glomerulonephritis with thrombotic microangiopathy in patients with systemic lupus erythematosus and lupus-like syndrome.
Charney DA; Nassar G; Truong L; Nadasdy T
Am J Kidney Dis; 2000 Jun; 35(6):1193-206. PubMed ID: 10845835
[TBL] [Abstract][Full Text] [Related]
30. Chemically modified ribozyme to V gene inhibits anti-DNA production and the formation of immune deposits caused by lupus lymphocytes.
Suzuki Y; Funato T; Munakata Y; Sato K; Hirabayashi Y; Ishii T; Takasawa N; Ootaka T; Saito T; Sasaki T
J Immunol; 2000 Nov; 165(10):5900-5. PubMed ID: 11067951
[TBL] [Abstract][Full Text] [Related]
31. Lupus nephritis: from pathogenesis to targets for biologic treatment.
Liu Y; Anders HJ
Nephron Clin Pract; 2014; 128(3-4):224-31. PubMed ID: 25401461
[TBL] [Abstract][Full Text] [Related]
32. Lupus nephritis: update on pathogenesis and disease mechanisms.
Foster MH; Kelley VR
Semin Nephrol; 1999 Mar; 19(2):173-81. PubMed ID: 10192250
[TBL] [Abstract][Full Text] [Related]
33. Endogenous interleukin (IL)-17A promotes pristane-induced systemic autoimmunity and lupus nephritis induced by pristane.
Summers SA; Odobasic D; Khouri MB; Steinmetz OM; Yang Y; Holdsworth SR; Kitching AR
Clin Exp Immunol; 2014 Jun; 176(3):341-50. PubMed ID: 24528105
[TBL] [Abstract][Full Text] [Related]
34. Antinuclear autoantibodies and lupus nephritis in transgenic mice expressing interferon gamma in the epidermis.
Seery JP; Carroll JM; Cattell V; Watt FM
J Exp Med; 1997 Nov; 186(9):1451-9. PubMed ID: 9348302
[TBL] [Abstract][Full Text] [Related]
35. Immunopathology of lupus nephritis.
Anders HJ; Fogo AB
Semin Immunopathol; 2014 Jul; 36(4):443-59. PubMed ID: 24402709
[TBL] [Abstract][Full Text] [Related]
36. Clonotypes of anti-DNA antibodies expressing specific idiotypes in immune complexes of patients with active lupus nephritis.
Muryoi T; Sasaki T; Hatakeyama A; Shibata S; Suzuki M; Seino J; Yoshinaga K
J Immunol; 1990 May; 144(10):3856-61. PubMed ID: 2332634
[TBL] [Abstract][Full Text] [Related]
37. Tubular basement membrane immune complex deposition is associated with activity and progression of lupus nephritis: a large multicenter Chinese study.
Wang H; Xu J; Zhang X; Ren YL; Cheng M; Guo ZL; Zhang JC; Cheng H; Xing GL; Wang SX; Yu F; Zhao MH
Lupus; 2018 Apr; 27(4):545-555. PubMed ID: 28954590
[TBL] [Abstract][Full Text] [Related]
38. Lupus nephritis: an historical perspective 1968-1998.
Cameron JS
J Nephrol; 1999; 12 Suppl 2():S29-41. PubMed ID: 10688400
[TBL] [Abstract][Full Text] [Related]
39. Bacterial lipopolysaccharide enhances deposition of immune complexes and exacerbates nephritis in BXSB lupus-prone mice.
Granholm NA; Cavallo T
Clin Exp Immunol; 1991 Aug; 85(2):270-7. PubMed ID: 1864008
[TBL] [Abstract][Full Text] [Related]
40. Clinicopathological characteristics and outcomes of Chinese patients with scanty immune deposits lupus nephritis: a large cohort study from a single center.
Li Q; Song D; Wang F; Tan Y; Yu F; Zhao M
ScientificWorldJournal; 2014; 2014():212597. PubMed ID: 24672300
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
